Corsair Pharma
Sunnyvale
About Corsair Pharma
Corsair Pharma is developing transformative solutions to the therapeutic profile of medications and provide superior treatment for patients.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $23.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Sep 2023)
- Website: corsairpharma.com
- Phone: [email protected]
Industries & Categories
Dietary Supplements, Manufacturing, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/corsair-pharma-11438 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.